SCHEMBL674114

SCHEMBL674114

O=C(N[C@H]1CC[C@H](C(F)(F)F)CC1)c1ccc(Cl)nc1OCCF.OCCF

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A12 P48065 1/20 0.39
IDH1 O75874 6/20 0.39
CNR1 P21554 5/20 0.39
CNR2 P34972 5/20 0.39
HPGD P15428 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
P2RX7 Q99572 1/20 0.37
PTGES O14684 4/20 0.37
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674115 1.00 SLC6A12 (0.39) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL10091473 0.98 SLC6A12 (0.41) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL674065 0.98 SLC6A12 (0.41) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL674066 0.98 SLC6A12 (0.41) SLC6A12IDH1CNR1CNR2HPGD
2-Methoxyethanol SCHEMBL675312 0.89 CNR1 (0.39) SLC6A12IDH1CNR1CNR2PTGES
2-Methoxyethanol SCHEMBL675311 0.89 CNR1 (0.39) SLC6A12IDH1CNR1CNR2PTGES
SCHEMBL672045 0.89 CNR1 (0.42) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL672044 0.89 CNR1 (0.42) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL674098 0.84 PTGES (0.47) SLC6A12IDH1CNR1CNR2HPGD
SCHEMBL674097 0.84 PTGES (0.47) SLC6A12IDH1CNR1CNR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606046-A1 2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2013-06-26 EP disclosed
WO-2012022792-A1 2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-23 WO disclosed